Boston Common Asset Management LLC Has $21.32 Million Stake in Colgate-Palmolive Company $CL

Boston Common Asset Management LLC raised its holdings in Colgate-Palmolive Company (NYSE:CLFree Report) by 7.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 250,152 shares of the company’s stock after buying an additional 16,502 shares during the period. Colgate-Palmolive accounts for about 1.4% of Boston Common Asset Management LLC’s portfolio, making the stock its 15th largest holding. Boston Common Asset Management LLC’s holdings in Colgate-Palmolive were worth $21,320,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CL. Teacher Retirement System of Texas raised its stake in shares of Colgate-Palmolive by 35.3% during the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock worth $37,110,000 after purchasing an additional 122,634 shares in the last quarter. Avior Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $1,135,000. Flputnam Investment Management Co. increased its holdings in Colgate-Palmolive by 7.4% during the fourth quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock worth $15,881,000 after buying an additional 13,804 shares during the last quarter. Caprock Group LLC increased its holdings in Colgate-Palmolive by 116.5% during the fourth quarter. Caprock Group LLC now owns 64,808 shares of the company’s stock worth $5,121,000 after buying an additional 34,879 shares during the last quarter. Finally, First Eagle Investment Management LLC raised its position in Colgate-Palmolive by 0.4% during the fourth quarter. First Eagle Investment Management LLC now owns 7,918,979 shares of the company’s stock worth $625,758,000 after acquiring an additional 29,876 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently commented on CL shares. The Goldman Sachs Group reissued a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Rothschild & Co Redburn set a $100.00 target price on shares of Colgate-Palmolive and gave the company a “buy” rating in a report on Tuesday, April 21st. Piper Sandler raised their target price on shares of Colgate-Palmolive from $92.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Royal Bank Of Canada reiterated an “outperform” rating and set a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Wells Fargo & Company boosted their price target on Colgate-Palmolive from $92.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 8th. Twelve investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $97.41.

Check Out Our Latest Report on CL

Colgate-Palmolive Price Performance

NYSE:CL opened at $92.84 on Monday. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a market cap of $74.29 billion, a P/E ratio of 36.12, a P/E/G ratio of 4.90 and a beta of 0.33. The firm’s fifty day moving average price is $90.46 and its two-hundred day moving average price is $88.60. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. Colgate-Palmolive’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.91 EPS. Equities analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be given a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.